Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
31
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Lamy Patrick | Senior VP, Commercial Strategy | 44 | $0 | $1.46M | 2025-12-09 |
| Judy Chou | Director | 10 | $0 | $0 | 2025-12-09 |
| Xu Yuan | Director | 12 | $0 | $0 | 2025-12-09 |
| Heyman Tomas J. | Director | 14 | $0 | $1.42M | 2025-12-09 |
| Young Jonathan | Chief Operating Officer | 138 | $0 | $13.41M | 2025-12-09 |
| Rolph Timothy | Chief Scientific Officer | 161 | $0 | $19.56M | 2025-12-09 |
| Yale Catriona | Chief Development Officer | 167 | $0 | $17.93M | 2025-12-09 |
| White William Richard | Chief Financial Officer | 121 | $0 | $14.99M | 2025-12-09 |
| Cheng Andrew | President and CEO | 228 | $0 | $43.39M | 2025-12-09 |
| Graham G. Walmsley | Director | 41 | $56.36M | $0 | 2025-12-09 |
| Gangloff Scott A. | Chief Technology Officer | 12 | $0 | $46.5K | 2025-12-09 |
| Henderson Jane | Director | 20 | $0 | $2.31M | 2025-12-09 |
| Iwicki Mark T | Director | 15 | $0 | $0 | 2025-12-09 |
| Harrison Seth Loring | Director, 10% Owner | 44 | $29.34M | $15.06M | 2025-12-09 |
| Skorpios Trust | Other | 1 | $0 | $71.17M | 2022-12-01 |
| ATP Life Science Ventures, L.P. | 10% Owner | 1 | $0 | $0 | 2021-06-28 |
| Bitterman Kevin | Director | 11 | $4.32M | $835.7K | 2021-06-01 |
| ATP III GP, Ltd. | 10% Owner | 6 | $29.34M | $0 | 2020-07-10 |
| venBio Global Strategic Fund II L.P. | 10% Owner | 7 | $0 | $5.94M | 2020-07-06 |
| GOODMAN COREY S | 10% Owner | 7 | $0 | $13.55M | 2020-03-06 |
| Adelman Robert J | 10% Owner | 5 | $0 | $1.19M | 2020-03-03 |
| venBio Global Strategic GP II, L.P. | 10% Owner | 6 | $0 | $406.1K | 2020-02-27 |
| Atlas Venture Opportunity Fund I, L.P. | 10% Owner | 3 | $0 | $0 | 2020-02-07 |
| Versant Ventures VI GP-GP, LLC | 10% Owner | 38 | $0 | $6.18M | 2020-01-21 |
| Versant Ventures VI GP, L.P. | 10% Owner | 3 | $0 | $1.06M | 2020-01-09 |
| Atlas Venture Fund XI, L.P. | 10% Owner | 1 | $0 | $0 | 2019-12-31 |
| Versant Venture Capital VI, L.P. | 10% Owner | 17 | $6.40M | $20.08M | 2019-12-31 |
| Atlas Venture Associates Opportunity I, LLC | 10% Owner | 5 | $4.32M | $0 | 2019-06-24 |
| venBio Global Strategic GP II, Ltd. | 10% Owner | 5 | $4.00M | $0 | 2019-06-24 |
| Royston Aaron | Director | 5 | $4.00M | $0 | 2019-06-24 |
| Green Jeremy | 10% Owner | 2 | $0 | $0 | 2019-06-24 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Young Jonathan | Chief Operating Officer | D To issuer deriv | 2025-12-09 | 2025-12-09 | 29,074 | — | $0 | 0 | SEC↗ |
| Young Jonathan | Chief Operating Officer | D To issuer deriv | 2025-12-09 | 2025-12-09 | 84,051 | — | $0 | 0 | SEC↗ |
| Young Jonathan | Chief Operating Officer | D To issuer deriv | 2025-12-09 | 2025-12-09 | 44,982 | — | $0 | 0 | SEC↗ |
| Young Jonathan | Chief Operating Officer | D To issuer deriv | 2025-12-09 | 2025-12-09 | 28,584 | — | $0 | 0 | SEC↗ |
| Young Jonathan | Chief Operating Officer | D To issuer deriv | 2025-12-09 | 2025-12-09 | 74,053 | — | $0 | 0 | SEC↗ |
| Young Jonathan | Chief Operating Officer | D To issuer deriv | 2025-12-09 | 2025-12-09 | 29,073 | — | $0 | 0 | SEC↗ |
| Young Jonathan | Chief Operating Officer | D To issuer deriv | 2025-12-09 | 2025-12-09 | 141,205 | — | $0 | 0 | SEC↗ |
| Young Jonathan | Chief Operating Officer | D To issuer deriv | 2025-12-09 | 2025-12-09 | 70,279 | — | $0 | 0 | SEC↗ |
| Young Jonathan | Chief Operating Officer | D To issuer deriv | 2025-12-09 | 2025-12-09 | 2,328 | — | $0 | 0 | SEC↗ |
| Young Jonathan | Chief Operating Officer | D To issuer deriv | 2025-12-09 | 2025-12-09 | 5,032 | — | $0 | 0 | SEC↗ |
| Young Jonathan | Chief Operating Officer | D To issuer deriv | 2025-12-09 | 2025-12-09 | 3,421 | — | $0 | 0 | SEC↗ |
| Henderson Jane | Director | D To issuer deriv | 2025-12-09 | 2025-12-09 | 11,797 | — | $0 | 0 | SEC↗ |
| Henderson Jane | Director | D To issuer deriv | 2025-12-09 | 2025-12-09 | 13,000 | — | $0 | 0 | SEC↗ |
| Henderson Jane | Director | D To issuer deriv | 2025-12-09 | 2025-12-09 | 13,000 | — | $0 | 0 | SEC↗ |
| Henderson Jane | Director | D To issuer deriv | 2025-12-09 | 2025-12-09 | 15,000 | — | $0 | 0 | SEC↗ |
| Henderson Jane | Director | D To issuer deriv | 2025-12-09 | 2025-12-09 | 26,000 | — | $0 | 0 | SEC↗ |
| Henderson Jane | Director | D To issuer deriv | 2025-12-09 | 2025-12-09 | 15,000 | — | $0 | 0 | SEC↗ |
| Lamy Patrick | See Remarks | D To issuer deriv | 2025-12-09 | 2025-12-09 | 84,904 | — | $0 | 0 | SEC↗ |
| Lamy Patrick | See Remarks | D To issuer deriv | 2025-12-09 | 2025-12-09 | 3,421 | — | $0 | 0 | SEC↗ |
| Lamy Patrick | See Remarks | D To issuer deriv | 2025-12-09 | 2025-12-09 | 382 | — | $0 | 0 | SEC↗ |
| Lamy Patrick | See Remarks | D To issuer deriv | 2025-12-09 | 2025-12-09 | 11,096 | — | $0 | 0 | SEC↗ |
| Lamy Patrick | See Remarks | D To issuer deriv | 2025-12-09 | 2025-12-09 | 48,679 | — | $0 | 0 | SEC↗ |
| Lamy Patrick | See Remarks | D To issuer deriv | 2025-12-09 | 2025-12-09 | 64,182 | — | $0 | 0 | SEC↗ |
| Yale Catriona | Chief Development Officer | D To issuer deriv | 2025-12-09 | 2025-12-09 | 3,421 | — | $0 | 0 | SEC↗ |
| Yale Catriona | Chief Development Officer | D To issuer deriv | 2025-12-09 | 2025-12-09 | 5,032 | — | $0 | 0 | SEC↗ |
| Yale Catriona | Chief Development Officer | D To issuer deriv | 2025-12-09 | 2025-12-09 | 2,328 | — | $0 | 0 | SEC↗ |
| Yale Catriona | Chief Development Officer | D To issuer deriv | 2025-12-09 | 2025-12-09 | 70,279 | — | $0 | 0 | SEC↗ |
| Yale Catriona | Chief Development Officer | D To issuer deriv | 2025-12-09 | 2025-12-09 | 131,205 | — | $0 | 0 | SEC↗ |
| Yale Catriona | Chief Development Officer | D To issuer deriv | 2025-12-09 | 2025-12-09 | 84,051 | — | $0 | 0 | SEC↗ |
| Yale Catriona | Chief Development Officer | D To issuer deriv | 2025-12-09 | 2025-12-09 | 33,421 | — | $0 | 0 | SEC↗ |
| Yale Catriona | Chief Development Officer | D To issuer deriv | 2025-12-09 | 2025-12-09 | 52,785 | — | $0 | 0 | SEC↗ |
| Yale Catriona | Chief Development Officer | D To issuer deriv | 2025-12-09 | 2025-12-09 | 74,053 | — | $0 | 0 | SEC↗ |
| White William Richard | Chief Financial Officer | D To issuer deriv | 2025-12-09 | 2025-12-09 | 74,053 | — | $0 | 0 | SEC↗ |
| White William Richard | Chief Financial Officer | D To issuer deriv | 2025-12-09 | 2025-12-09 | 24,745 | — | $0 | 0 | SEC↗ |
| White William Richard | Chief Financial Officer | D To issuer deriv | 2025-12-09 | 2025-12-09 | 29,073 | — | $0 | 0 | SEC↗ |
| White William Richard | Chief Financial Officer | D To issuer deriv | 2025-12-09 | 2025-12-09 | 29,074 | — | $0 | 0 | SEC↗ |
| White William Richard | Chief Financial Officer | D To issuer deriv | 2025-12-09 | 2025-12-09 | 29,074 | — | $0 | 0 | SEC↗ |
| White William Richard | Chief Financial Officer | D To issuer deriv | 2025-12-09 | 2025-12-09 | 82,482 | — | $0 | 0 | SEC↗ |
| White William Richard | Chief Financial Officer | D To issuer deriv | 2025-12-09 | 2025-12-09 | 84,051 | — | $0 | 0 | SEC↗ |
| White William Richard | Chief Financial Officer | D To issuer deriv | 2025-12-09 | 2025-12-09 | 83,400 | — | $0 | 0 | SEC↗ |
| White William Richard | Chief Financial Officer | D To issuer deriv | 2025-12-09 | 2025-12-09 | 116,833 | — | $0 | 0 | SEC↗ |
| White William Richard | Chief Financial Officer | D To issuer deriv | 2025-12-09 | 2025-12-09 | 70,279 | — | $0 | 0 | SEC↗ |
| White William Richard | Chief Financial Officer | D To issuer deriv | 2025-12-09 | 2025-12-09 | 18,964 | — | $0 | 0 | SEC↗ |
| White William Richard | Chief Financial Officer | D To issuer deriv | 2025-12-09 | 2025-12-09 | 3,527 | — | $0 | 0 | SEC↗ |
| White William Richard | Chief Financial Officer | D To issuer deriv | 2025-12-09 | 2025-12-09 | 3,421 | — | $0 | 0 | SEC↗ |
| White William Richard | Chief Financial Officer | D To issuer deriv | 2025-12-09 | 2025-12-09 | 5,032 | — | $0 | 0 | SEC↗ |
| White William Richard | Chief Financial Officer | D To issuer deriv | 2025-12-09 | 2025-12-09 | 2,328 | — | $0 | 0 | SEC↗ |
| White William Richard | Chief Financial Officer | D To issuer deriv | 2025-12-09 | 2025-12-09 | 4,739 | — | $0 | 0 | SEC↗ |
| Gangloff Scott A. | Chief Technology Officer | D To issuer deriv | 2025-12-09 | 2025-12-09 | 204,616 | — | $0 | 0 | SEC↗ |
| Gangloff Scott A. | Chief Technology Officer | D To issuer deriv | 2025-12-09 | 2025-12-09 | 73,700 | — | $0 | 0 | SEC↗ |
| Gangloff Scott A. | Chief Technology Officer | D To issuer deriv | 2025-12-09 | 2025-12-09 | 17,784 | — | $0 | 0 | SEC↗ |
| Iwicki Mark T | Director | D To issuer deriv | 2025-12-09 | 2025-12-09 | 26,000 | — | $0 | 0 | SEC↗ |
| Iwicki Mark T | Director | D To issuer deriv | 2025-12-09 | 2025-12-09 | 76,227 | — | $0 | 0 | SEC↗ |
| Iwicki Mark T | Director | D To issuer deriv | 2025-12-09 | 2025-12-09 | 15,000 | — | $0 | 0 | SEC↗ |
| Iwicki Mark T | Director | D To issuer deriv | 2025-12-09 | 2025-12-09 | 11,493 | — | $0 | 0 | SEC↗ |
| Iwicki Mark T | Director | D To issuer deriv | 2025-12-09 | 2025-12-09 | 70,587 | — | $0 | 0 | SEC↗ |
| Iwicki Mark T | Director | D To issuer deriv | 2025-12-09 | 2025-12-09 | 13,000 | — | $0 | 0 | SEC↗ |
| Iwicki Mark T | Director | D To issuer deriv | 2025-12-09 | 2025-12-09 | 13,000 | — | $0 | 0 | SEC↗ |
| Iwicki Mark T | Director | D To issuer deriv | 2025-12-09 | 2025-12-09 | 15,000 | — | $0 | 0 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | D To issuer deriv | 2025-12-09 | 2025-12-09 | 389 | — | $0 | 0 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | D To issuer deriv | 2025-12-09 | 2025-12-09 | 49,945 | — | $0 | 0 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | D To issuer deriv | 2025-12-09 | 2025-12-09 | 29,074 | — | $0 | 0 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | D To issuer deriv | 2025-12-09 | 2025-12-09 | 29,074 | — | $0 | 0 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | D To issuer deriv | 2025-12-09 | 2025-12-09 | 26,152 | — | $0 | 0 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | D To issuer deriv | 2025-12-09 | 2025-12-09 | 84,051 | — | $0 | 0 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | D To issuer deriv | 2025-12-09 | 2025-12-09 | 119,969 | — | $0 | 0 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | D To issuer deriv | 2025-12-09 | 2025-12-09 | 56,579 | — | $0 | 0 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | D To issuer deriv | 2025-12-09 | 2025-12-09 | 2,328 | — | $0 | 0 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | D To issuer deriv | 2025-12-09 | 2025-12-09 | 5,032 | — | $0 | 0 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | D To issuer deriv | 2025-12-09 | 2025-12-09 | 3,421 | — | $0 | 0 | SEC↗ |
| Judy Chou | Director | D To issuer deriv | 2025-12-09 | 2025-12-09 | 26,000 | — | $0 | 0 | SEC↗ |
| Judy Chou | Director | D To issuer deriv | 2025-12-09 | 2025-12-09 | 15,000 | — | $0 | 0 | SEC↗ |
| Judy Chou | Director | D To issuer deriv | 2025-12-09 | 2025-12-09 | 15,000 | — | $0 | 0 | SEC↗ |
| Judy Chou | Director | D To issuer deriv | 2025-12-09 | 2025-12-09 | 26,000 | — | $0 | 0 | SEC↗ |
| Graham G. Walmsley | Director | D To issuer deriv | 2025-12-09 | 2025-12-09 | 15,000 | — | $0 | 0 | SEC↗ |
| Harrison Seth Loring | Director | D To issuer deriv | 2025-12-09 | 2025-12-09 | 26,000 | — | $0 | 0 | SEC↗ |
| Harrison Seth Loring | Director | D To issuer deriv | 2025-12-09 | 2025-12-09 | 26,000 | — | $0 | 0 | SEC↗ |
| Harrison Seth Loring | Director | D To issuer deriv | 2025-12-09 | 2025-12-09 | 15,000 | — | $0 | 0 | SEC↗ |
| Harrison Seth Loring | Director | D To issuer deriv | 2025-12-09 | 2025-12-09 | 13,000 | — | $0 | 0 | SEC↗ |
| Harrison Seth Loring | Director | D To issuer deriv | 2025-12-09 | 2025-12-09 | 15,000 | — | $0 | 0 | SEC↗ |
| Harrison Seth Loring | Director | D To issuer deriv | 2025-12-09 | 2025-12-09 | 13,000 | — | $0 | 0 | SEC↗ |
| Cheng Andrew | President and CEO | D To issuer deriv | 2025-12-09 | 2025-12-09 | 23,809 | — | $0 | 0 | SEC↗ |
| Cheng Andrew | President and CEO | D To issuer deriv | 2025-12-09 | 2025-12-09 | 3,421 | — | $0 | 0 | SEC↗ |
| Cheng Andrew | President and CEO | D To issuer deriv | 2025-12-09 | 2025-12-09 | 5,032 | — | $0 | 0 | SEC↗ |
| Cheng Andrew | President and CEO | D To issuer deriv | 2025-12-09 | 2025-12-09 | 2,328 | — | $0 | 0 | SEC↗ |
| Cheng Andrew | President and CEO | D To issuer deriv | 2025-12-09 | 2025-12-09 | 4,739 | — | $0 | 0 | SEC↗ |
| Cheng Andrew | President and CEO | D To issuer deriv | 2025-12-09 | 2025-12-09 | 3,527 | — | $0 | 0 | SEC↗ |
| Cheng Andrew | President and CEO | D To issuer deriv | 2025-12-09 | 2025-12-09 | 292,179 | — | $0 | 0 | SEC↗ |
| Cheng Andrew | President and CEO | D To issuer deriv | 2025-12-09 | 2025-12-09 | 374,985 | — | $0 | 0 | SEC↗ |
| Cheng Andrew | President and CEO | D To issuer deriv | 2025-12-09 | 2025-12-09 | 233,252 | — | $0 | 0 | SEC↗ |
| Cheng Andrew | President and CEO | D To issuer deriv | 2025-12-09 | 2025-12-09 | 165,289 | — | $0 | 0 | SEC↗ |
| Cheng Andrew | President and CEO | D To issuer deriv | 2025-12-09 | 2025-12-09 | 10,000 | — | $0 | 0 | SEC↗ |
| Cheng Andrew | President and CEO | D To issuer deriv | 2025-12-09 | 2025-12-09 | 234,000 | — | $0 | 0 | SEC↗ |
| Cheng Andrew | President and CEO | D To issuer deriv | 2025-12-09 | 2025-12-09 | 238,973 | — | $0 | 0 | SEC↗ |
| Cheng Andrew | President and CEO | D To issuer deriv | 2025-12-09 | 2025-12-09 | 87,220 | — | $0 | 0 | SEC↗ |
| Xu Yuan | Director | D To issuer deriv | 2025-12-09 | 2025-12-09 | 26,000 | — | $0 | 0 | SEC↗ |
| Xu Yuan | Director | D To issuer deriv | 2025-12-09 | 2025-12-09 | 26,000 | — | $0 | 0 | SEC↗ |
| Xu Yuan | Director | D To issuer deriv | 2025-12-09 | 2025-12-09 | 15,000 | — | $0 | 0 | SEC↗ |
| Xu Yuan | Director | D To issuer deriv | 2025-12-09 | 2025-12-09 | 15,000 | — | $0 | 0 | SEC↗ |
| Xu Yuan | Director | D To issuer deriv | 2025-12-09 | 2025-12-09 | 13,000 | — | $0 | 0 | SEC↗ |
| Heyman Tomas J. | Director | D To issuer deriv | 2025-12-09 | 2025-12-09 | 13,000 | — | $0 | 0 | SEC↗ |
| Heyman Tomas J. | Director | D To issuer deriv | 2025-12-09 | 2025-12-09 | 15,000 | — | $0 | 0 | SEC↗ |
| Heyman Tomas J. | Director | D To issuer deriv | 2025-12-09 | 2025-12-09 | 15,000 | — | $0 | 0 | SEC↗ |
| Heyman Tomas J. | Director | D To issuer deriv | 2025-12-09 | 2025-12-09 | 26,000 | — | $0 | 0 | SEC↗ |
| Young Jonathan | Chief Operating Officer | D To issuer | 2025-12-09 | 2025-12-09 | 152,616 | — | $0 | 0 | SEC↗ |
| Young Jonathan | Chief Operating Officer | D To issuer | 2025-12-09 | 2025-12-09 | 20,000 | — | $0 | 0 | SEC↗ |
| Young Jonathan | Chief Operating Officer | D To issuer | 2025-12-09 | 2025-12-09 | 47,573 | — | $0 | 0 | SEC↗ |
| Young Jonathan | Chief Operating Officer | D To issuer | 2025-12-09 | 2025-12-09 | 20,000 | — | $0 | 0 | SEC↗ |
| Young Jonathan | Chief Operating Officer | D To issuer | 2025-12-09 | 2025-12-09 | 20,000 | — | $0 | 0 | SEC↗ |
| Henderson Jane | Director | D To issuer | 2025-12-09 | 2025-12-09 | 9,398 | — | $0 | 0 | SEC↗ |
| Lamy Patrick | See Remarks | D To issuer | 2025-12-09 | 2025-12-09 | 26,832 | — | $0 | 0 | SEC↗ |
| Lamy Patrick | See Remarks | D To issuer | 2025-12-09 | 2025-12-09 | 3,059 | — | $0 | 0 | SEC↗ |
| Yale Catriona | Chief Development Officer | D To issuer | 2025-12-09 | 2025-12-09 | 47,573 | — | $0 | 0 | SEC↗ |
| Yale Catriona | Chief Development Officer | D To issuer | 2025-12-09 | 2025-12-09 | 27,227 | — | $0 | 0 | SEC↗ |
| White William Richard | Chief Financial Officer | D To issuer | 2025-12-09 | 2025-12-09 | 10,179 | — | $0 | 0 | SEC↗ |
| White William Richard | Chief Financial Officer | D To issuer | 2025-12-09 | 2025-12-09 | 47,573 | — | $0 | 0 | SEC↗ |
| Gangloff Scott A. | Chief Technology Officer | D To issuer | 2025-12-09 | 2025-12-09 | 5,088 | — | $0 | 0 | SEC↗ |
| Gangloff Scott A. | Chief Technology Officer | D To issuer | 2025-12-09 | 2025-12-09 | 21,263 | — | $0 | 0 | SEC↗ |
| Iwicki Mark T | Director | D To issuer | 2025-12-09 | 2025-12-09 | 9,398 | — | $0 | 0 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | D To issuer | 2025-12-09 | 2025-12-09 | 238,339 | — | $0 | 0 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | D To issuer | 2025-12-09 | 2025-12-09 | 43,810 | — | $0 | 0 | SEC↗ |
| Judy Chou | Director | D To issuer | 2025-12-09 | 2025-12-09 | 9,398 | — | $0 | 0 | SEC↗ |
| Graham G. Walmsley | Director | D To issuer | 2025-12-09 | 2025-12-09 | 93,000 | — | $0 | 0 | SEC↗ |
| Graham G. Walmsley | Director | D To issuer | 2025-12-09 | 2025-12-09 | 1,200,000 | — | $0 | 0 | SEC↗ |
| Graham G. Walmsley | Director | D To issuer | 2025-12-09 | 2025-12-09 | 9,398 | — | $0 | 0 | SEC↗ |
| Harrison Seth Loring | Director | D To issuer | 2025-12-09 | 2025-12-09 | 9,398 | — | $0 | 0 | SEC↗ |
| Harrison Seth Loring | Director | D To issuer | 2025-12-09 | 2025-12-09 | 136,301 | — | $0 | 0 | SEC↗ |
| Harrison Seth Loring | Director | D To issuer | 2025-12-09 | 2025-12-09 | 148,063 | — | $0 | 0 | SEC↗ |
| Cheng Andrew | President and CEO | D To issuer | 2025-12-09 | 2025-12-09 | 277,075 | — | $0 | 0 | SEC↗ |
| Cheng Andrew | President and CEO | D To issuer | 2025-12-09 | 2025-12-09 | 159,762 | — | $0 | 0 | SEC↗ |
| Xu Yuan | Director | D To issuer | 2025-12-09 | 2025-12-09 | 9,398 | — | $0 | 0 | SEC↗ |
| Heyman Tomas J. | Director | D To issuer | 2025-12-09 | 2025-12-09 | 9,398 | — | $0 | 0 | SEC↗ |
| Young Jonathan | Chief Operating Officer | G Gift | 2025-11-26 | 2025-11-26 | 9,259 | — | $0 | 200,189 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | M Exercise deriv | 2025-11-25 | 2025-11-28 | 43,064 | — | $0 | 0 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | M Exercise deriv | 2025-11-25 | 2025-11-28 | 3,527 | — | $0 | 0 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | M Exercise deriv | 2025-11-25 | 2025-11-28 | 4,284 | — | $0 | 0 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | M Exercise deriv | 2025-11-25 | 2025-11-28 | 4,739 | — | $0 | 0 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | M Exercise deriv | 2025-11-25 | 2025-11-28 | 94,268 | — | $0 | 0 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | M Exercise deriv | 2025-11-25 | 2025-11-28 | 2,796 | — | $0 | 0 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | M Exercise | 2025-11-25 | 2025-11-28 | 2,796 | $0.62 | $1.7K | 183,142 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | M Exercise | 2025-11-25 | 2025-11-28 | 3,527 | $28.35 | $100.0K | 132,998 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | M Exercise | 2025-11-25 | 2025-11-28 | 43,064 | $6.36 | $273.9K | 176,062 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | M Exercise | 2025-11-25 | 2025-11-28 | 4,284 | $21.09 | $90.3K | 180,346 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | M Exercise | 2025-11-25 | 2025-11-28 | 94,268 | $0.62 | $58.4K | 277,410 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | M Exercise | 2025-11-25 | 2025-11-28 | 4,739 | $21.10 | $100.0K | 282,149 | SEC↗ |
| Young Jonathan | Chief Operating Officer | M Exercise deriv | 2025-11-24 | 2025-11-26 | 4,739 | — | $0 | 0 | SEC↗ |
| Young Jonathan | Chief Operating Officer | M Exercise deriv | 2025-11-24 | 2025-11-26 | 3,527 | — | $0 | 0 | SEC↗ |
| Young Jonathan | Chief Operating Officer | M Exercise deriv | 2025-11-24 | 2025-11-26 | 4,284 | — | $0 | 0 | SEC↗ |
| Young Jonathan | Chief Operating Officer | M Exercise | 2025-11-24 | 2025-11-26 | 3,527 | $28.35 | $100.0K | 204,709 | SEC↗ |
| Young Jonathan | Chief Operating Officer | M Exercise | 2025-11-24 | 2025-11-26 | 4,739 | $21.10 | $100.0K | 209,448 | SEC↗ |
| Young Jonathan | Chief Operating Officer | M Exercise | 2025-11-24 | 2025-11-26 | 4,284 | $21.09 | $90.3K | 201,182 | SEC↗ |
| Cheng Andrew | President and CEO | G Gift | 2025-11-20 | 2025-11-21 | 74,538 | — | $0 | 436,837 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | G Gift | 2025-11-17 | 2025-11-19 | 37,100 | — | $0 | 129,471 | SEC↗ |
| Cheng Andrew | President and CEO | G Gift | 2025-11-12 | 2025-11-13 | 14,739 | — | $0 | 511,375 | SEC↗ |
| Yale Catriona | Chief Development Officer | M Exercise deriv | 2025-11-04 | 2025-11-06 | 3,527 | — | $0 | 0 | SEC↗ |
| Yale Catriona | Chief Development Officer | M Exercise deriv | 2025-11-04 | 2025-11-06 | 4,739 | — | $0 | 0 | SEC↗ |
| Yale Catriona | Chief Development Officer | M Exercise | 2025-11-04 | 2025-11-06 | 4,739 | $21.10 | $100.0K | 74,800 | SEC↗ |
| Yale Catriona | Chief Development Officer | M Exercise | 2025-11-04 | 2025-11-06 | 3,527 | $28.35 | $100.0K | 70,061 | SEC↗ |
| Cheng Andrew | President and CEO | M Exercise deriv | 2025-10-10 | 2025-10-14 | 30,000 | — | $0 | 380,017 | SEC↗ |
| Cheng Andrew | President and CEO | S Sale | 2025-10-10 | 2025-10-14 | 30,000 | $53.98 | $1.62M | 526,114 | SEC↗ |
| Cheng Andrew | President and CEO | M Exercise | 2025-10-10 | 2025-10-14 | 30,000 | $19.87 | $596.1K | 556,114 | SEC↗ |
| Cheng Andrew | President and CEO | M Exercise deriv | 2025-10-08 | 2025-10-09 | 52,212 | — | $0 | 0 | SEC↗ |
| Graham G. Walmsley | Director | M Exercise deriv | 2025-10-08 | 2025-10-10 | 13,000 | — | $0 | 0 | SEC↗ |
| Graham G. Walmsley | Director | M Exercise deriv | 2025-10-08 | 2025-10-10 | 15,000 | — | $0 | 0 | SEC↗ |
| Graham G. Walmsley | Director | M Exercise deriv | 2025-10-08 | 2025-10-10 | 26,000 | — | $0 | 0 | SEC↗ |
| Graham G. Walmsley | Director | M Exercise deriv | 2025-10-08 | 2025-10-10 | 23,832 | — | $0 | 0 | SEC↗ |
| Graham G. Walmsley | Director | M Exercise deriv | 2025-10-08 | 2025-10-10 | 13,000 | — | $0 | 0 | SEC↗ |
| Cheng Andrew | President and CEO | M Exercise | 2025-10-08 | 2025-10-09 | 52,212 | $0.62 | $32.4K | 526,114 | SEC↗ |
| Graham G. Walmsley | Director | M Exercise | 2025-10-08 | 2025-10-10 | 23,832 | $19.97 | $475.9K | 93,000 | SEC↗ |
| Graham G. Walmsley | Director | M Exercise | 2025-10-08 | 2025-10-10 | 26,000 | $23.02 | $598.5K | 28,168 | SEC↗ |
| Graham G. Walmsley | Director | M Exercise | 2025-10-08 | 2025-10-10 | 15,000 | $8.13 | $122.0K | 43,168 | SEC↗ |
| Graham G. Walmsley | Director | M Exercise | 2025-10-08 | 2025-10-10 | 13,000 | $26.32 | $342.2K | 56,168 | SEC↗ |
| Graham G. Walmsley | Director | M Exercise | 2025-10-08 | 2025-10-10 | 13,000 | $25.20 | $327.6K | 69,168 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | M Exercise deriv | 2025-10-07 | 2025-10-09 | 12,500 | — | $0 | 49,945 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | S Sale | 2025-10-07 | 2025-10-09 | 1,037 | $46.82 | $48.6K | 166,571 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | S Sale | 2025-10-07 | 2025-10-09 | 11,463 | $46.01 | $527.4K | 167,608 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | M Exercise | 2025-10-07 | 2025-10-09 | 12,500 | $28.35 | $354.4K | 179,071 | SEC↗ |
| Young Jonathan | Chief Operating Officer | M Exercise deriv | 2025-10-01 | 2025-10-03 | 12,500 | — | $0 | 44,982 | SEC↗ |
| Young Jonathan | Chief Operating Officer | S Sale | 2025-10-01 | 2025-10-03 | 4,201 | $47.98 | $201.6K | 196,898 | SEC↗ |
| Young Jonathan | Chief Operating Officer | S Sale | 2025-10-01 | 2025-10-03 | 8,299 | $47.64 | $395.4K | 201,099 | SEC↗ |
| Young Jonathan | Chief Operating Officer | M Exercise | 2025-10-01 | 2025-10-03 | 12,500 | $21.10 | $263.8K | 209,398 | SEC↗ |
| Cheng Andrew | President and CEO | S Sale | 2025-09-11 | 2025-09-12 | 1,796 | $43.02 | $77.3K | 473,902 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | S Sale | 2025-09-11 | 2025-09-12 | 553 | $43.02 | $23.8K | 166,571 | SEC↗ |
| White William Richard | Chief Financial Officer | S Sale | 2025-09-11 | 2025-09-12 | 659 | $43.02 | $28.4K | 57,752 | SEC↗ |
| Yale Catriona | Chief Development Officer | S Sale | 2025-09-11 | 2025-09-12 | 659 | $43.02 | $28.4K | 90,829 | SEC↗ |
| Young Jonathan | Chief Operating Officer | S Sale | 2025-09-11 | 2025-09-12 | 586 | $43.02 | $25.2K | 196,898 | SEC↗ |
| Cheng Andrew | President and CEO | M Exercise deriv | 2025-09-10 | 2025-09-12 | 13,022 | — | $0 | 0 | SEC↗ |
| Cheng Andrew | President and CEO | M Exercise deriv | 2025-09-10 | 2025-09-12 | 1,919 | — | $0 | 410,017 | SEC↗ |
| Cheng Andrew | President and CEO | S Sale | 2025-09-10 | 2025-09-12 | 158 | $44.62 | $7.0K | 475,698 | SEC↗ |
| Cheng Andrew | President and CEO | M Exercise | 2025-09-10 | 2025-09-12 | 13,022 | $6.36 | $82.8K | 503,779 | SEC↗ |
| Cheng Andrew | President and CEO | M Exercise | 2025-09-10 | 2025-09-12 | 1,919 | $19.87 | $38.1K | 505,698 | SEC↗ |
| Cheng Andrew | President and CEO | S Sale | 2025-09-10 | 2025-09-12 | 22,525 | $42.99 | $968.3K | 483,173 | SEC↗ |
| Cheng Andrew | President and CEO | S Sale | 2025-09-10 | 2025-09-12 | 7,317 | $44.00 | $321.9K | 475,856 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | M Exercise deriv | 2025-09-08 | 2025-09-10 | 295 | — | $0 | 62,445 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | M Exercise deriv | 2025-09-08 | 2025-09-10 | 5,161 | — | $0 | 0 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | M Exercise deriv | 2025-09-08 | 2025-09-10 | 7,044 | — | $0 | 389 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | M Exercise | 2025-09-08 | 2025-09-10 | 295 | $28.35 | $8.4K | 179,624 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | M Exercise | 2025-09-08 | 2025-09-10 | 7,044 | $21.09 | $148.6K | 174,168 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | S Sale | 2025-09-08 | 2025-09-10 | 12,466 | $44.17 | $550.6K | 167,158 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | S Sale | 2025-09-08 | 2025-09-10 | 34 | $44.88 | $1.5K | 167,124 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | M Exercise | 2025-09-08 | 2025-09-10 | 5,161 | $6.36 | $32.8K | 179,329 | SEC↗ |
| Young Jonathan | Chief Operating Officer | M Exercise deriv | 2025-09-02 | 2025-09-04 | 12,500 | — | $0 | 57,482 | SEC↗ |
| Young Jonathan | Chief Operating Officer | S Sale | 2025-09-02 | 2025-09-04 | 2,739 | $47.14 | $129.1K | 197,545 | SEC↗ |
| Young Jonathan | Chief Operating Officer | S Sale | 2025-09-02 | 2025-09-04 | 61 | $47.58 | $2.9K | 197,484 | SEC↗ |
| Young Jonathan | Chief Operating Officer | M Exercise | 2025-09-02 | 2025-09-04 | 12,500 | $21.10 | $263.8K | 209,984 | SEC↗ |
| Young Jonathan | Chief Operating Officer | S Sale | 2025-09-02 | 2025-09-04 | 9,700 | $45.78 | $444.1K | 200,284 | SEC↗ |
| Gangloff Scott A. | Chief Technology Officer | M Exercise deriv | 2025-08-15 | 2025-08-19 | 2,600 | — | $0 | 17,784 | SEC↗ |
| Gangloff Scott A. | Chief Technology Officer | M Exercise | 2025-08-15 | 2025-08-19 | 2,600 | $19.62 | $51.0K | 26,351 | SEC↗ |
| Henderson Jane | Director | M Exercise deriv | 2025-08-12 | 2025-08-12 | 3,000 | — | $0 | 11,797 | SEC↗ |
| Young Jonathan | Chief Operating Officer | M Exercise deriv | 2025-08-12 | 2025-08-13 | 12,500 | — | $0 | 69,982 | SEC↗ |
| Henderson Jane | Director | M Exercise | 2025-08-12 | 2025-08-12 | 3,000 | $7.01 | $21.0K | 12,398 | SEC↗ |
| Henderson Jane | Director | S Sale | 2025-08-12 | 2025-08-12 | 3,000 | $47.46 | $142.4K | 9,398 | SEC↗ |
| Young Jonathan | Chief Operating Officer | S Sale | 2025-08-12 | 2025-08-13 | 1,349 | $48.32 | $65.2K | 197,484 | SEC↗ |
| Young Jonathan | Chief Operating Officer | S Sale | 2025-08-12 | 2025-08-13 | 11,151 | $47.72 | $532.1K | 198,833 | SEC↗ |
| Young Jonathan | Chief Operating Officer | M Exercise | 2025-08-12 | 2025-08-13 | 12,500 | $21.10 | $263.8K | 209,984 | SEC↗ |
| Cheng Andrew | President and CEO | S Sale | 2025-08-11 | 2025-08-13 | 18,805 | $48.87 | $919.0K | 491,157 | SEC↗ |
| Cheng Andrew | President and CEO | S Sale | 2025-08-11 | 2025-08-13 | 400 | $49.44 | $19.8K | 490,757 | SEC↗ |
| Cheng Andrew | President and CEO | S Sale | 2025-08-11 | 2025-08-13 | 10,795 | $48.07 | $518.9K | 509,962 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | M Exercise deriv | 2025-08-05 | 2025-08-07 | 12,500 | — | $0 | 7,433 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | S Sale | 2025-08-05 | 2025-08-07 | 6,962 | $49.49 | $344.5K | 167,124 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | S Sale | 2025-08-05 | 2025-08-07 | 5,538 | $49.07 | $271.7K | 174,086 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | M Exercise | 2025-08-05 | 2025-08-07 | 12,500 | $21.09 | $263.6K | 179,624 | SEC↗ |
| Yale Catriona | Chief Development Officer | M Exercise deriv | 2025-07-16 | 2025-07-18 | 10,000 | — | $0 | 131,205 | SEC↗ |
| Yale Catriona | Chief Development Officer | S Sale | 2025-07-16 | 2025-07-18 | 1,342 | $53.47 | $71.8K | 91,488 | SEC↗ |
| Yale Catriona | Chief Development Officer | S Sale | 2025-07-16 | 2025-07-18 | 8,658 | $52.87 | $457.7K | 92,830 | SEC↗ |
| Yale Catriona | Chief Development Officer | M Exercise | 2025-07-16 | 2025-07-18 | 10,000 | $19.87 | $198.7K | 101,488 | SEC↗ |
| Cheng Andrew | President and CEO | S Sale | 2025-07-10 | 2025-07-11 | 15,314 | $51.73 | $792.2K | 520,757 | SEC↗ |
| Cheng Andrew | President and CEO | S Sale | 2025-07-10 | 2025-07-11 | 14,686 | $50.57 | $742.7K | 536,071 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | M Exercise deriv | 2025-07-07 | 2025-07-09 | 12,500 | — | $0 | 19,933 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | S Sale | 2025-07-07 | 2025-07-09 | 10,634 | $50.93 | $541.6K | 168,990 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | M Exercise | 2025-07-07 | 2025-07-09 | 12,500 | $21.09 | $263.6K | 179,624 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | S Sale | 2025-07-07 | 2025-07-09 | 1,825 | $52.00 | $94.9K | 167,165 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | S Sale | 2025-07-07 | 2025-07-09 | 41 | $52.62 | $2.2K | 167,124 | SEC↗ |
| Lamy Patrick | Senior VP, Commercial Strate | S Sale | 2025-07-01 | 2025-07-03 | 2,000 | $52.88 | $105.8K | 29,891 | SEC↗ |
| Cheng Andrew | President and CEO | A Award | 2025-06-30 | 2025-07-02 | 890 | $23.87 | $21.2K | 550,757 | SEC↗ |
| Gangloff Scott A. | Chief Technology Officer | A Award | 2025-06-30 | 2025-07-02 | 299 | $23.87 | $7.1K | 23,751 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | A Award | 2025-06-30 | 2025-07-02 | 890 | $23.87 | $21.2K | 167,124 | SEC↗ |
| White William Richard | Chief Financial Officer | A Award | 2025-06-30 | 2025-07-02 | 890 | $23.87 | $21.2K | 58,411 | SEC↗ |
| Lamy Patrick | Senior VP, Commercial Strate | A Award | 2025-06-30 | 2025-07-02 | 193 | $23.87 | $4.6K | 31,891 | SEC↗ |
| Yale Catriona | Chief Development Officer | A Award | 2025-06-30 | 2025-07-02 | 890 | $23.87 | $21.2K | 91,488 | SEC↗ |
| Young Jonathan | Chief Operating Officer | A Award | 2025-06-30 | 2025-07-02 | 890 | $23.87 | $21.2K | 197,484 | SEC↗ |
| Lamy Patrick | Senior VP, Commercial Strate | S Sale | 2025-06-20 | 2025-06-20 | 875 | $54.59 | $47.8K | 31,698 | SEC↗ |
| Young Jonathan | Chief Operating Officer | S Sale | 2025-06-18 | 2025-06-20 | 1,453 | $54.84 | $79.7K | 196,594 | SEC↗ |
| Yale Catriona | Chief Development Officer | S Sale | 2025-06-18 | 2025-06-20 | 1,633 | $54.84 | $89.6K | 90,598 | SEC↗ |
| White William Richard | Chief Financial Officer | S Sale | 2025-06-18 | 2025-06-20 | 1,634 | $54.84 | $89.6K | 57,521 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | S Sale | 2025-06-18 | 2025-06-20 | 1,129 | $54.84 | $61.9K | 166,234 | SEC↗ |
| Gangloff Scott A. | Chief Technology Officer | S Sale | 2025-06-18 | 2025-06-20 | 848 | $54.84 | $46.5K | 23,452 | SEC↗ |
| Cheng Andrew | President and CEO | S Sale | 2025-06-18 | 2025-06-20 | 6,620 | $54.84 | $363.0K | 549,867 | SEC↗ |
| Lamy Patrick | Senior VP, Commercial Strate | M Exercise deriv | 2025-06-16 | 2025-06-20 | 2,000 | — | $0 | 64,182 | SEC↗ |
| Yale Catriona | Chief Development Officer | M Exercise deriv | 2025-06-16 | 2025-06-20 | 10,000 | — | $0 | 0 | SEC↗ |
| Lamy Patrick | Senior VP, Commercial Strate | S Sale | 2025-06-16 | 2025-06-20 | 500 | $55.09 | $27.5K | 32,573 | SEC↗ |
| Lamy Patrick | Senior VP, Commercial Strate | M Exercise | 2025-06-16 | 2025-06-20 | 2,000 | $19.87 | $39.7K | 34,573 | SEC↗ |
| Lamy Patrick | Senior VP, Commercial Strate | S Sale | 2025-06-16 | 2025-06-20 | 1,500 | $53.82 | $80.7K | 33,073 | SEC↗ |
| Yale Catriona | Chief Development Officer | S Sale | 2025-06-16 | 2025-06-20 | 895 | $55.52 | $49.7K | 92,231 | SEC↗ |
| Yale Catriona | Chief Development Officer | S Sale | 2025-06-16 | 2025-06-20 | 6,210 | $53.78 | $334.0K | 96,021 | SEC↗ |
| Yale Catriona | Chief Development Officer | M Exercise | 2025-06-16 | 2025-06-20 | 10,000 | $21.10 | $211.0K | 102,231 | SEC↗ |
| Yale Catriona | Chief Development Officer | S Sale | 2025-06-16 | 2025-06-20 | 2,895 | $54.80 | $158.6K | 93,126 | SEC↗ |
| Young Jonathan | Chief Operating Officer | S Sale | 2025-06-10 | 2025-06-12 | 2,493 | $53.99 | $134.6K | 198,047 | SEC↗ |
| Lamy Patrick | Senior VP, Commercial Strate | S Sale | 2025-06-10 | 2025-06-12 | 919 | $54.00 | $49.6K | 32,573 | SEC↗ |
| Yale Catriona | Chief Development Officer | S Sale | 2025-06-10 | 2025-06-12 | 2,803 | $54.00 | $151.4K | 92,231 | SEC↗ |
| White William Richard | Chief Financial Officer | S Sale | 2025-06-10 | 2025-06-12 | 2,804 | $54.00 | $151.4K | 59,155 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | S Sale | 2025-06-10 | 2025-06-12 | 2,358 | $54.00 | $127.3K | 167,363 | SEC↗ |
| Cheng Andrew | President and CEO | S Sale | 2025-06-10 | 2025-06-12 | 15,158 | $54.35 | $823.8K | 564,324 | SEC↗ |
| Cheng Andrew | President and CEO | S Sale | 2025-06-10 | 2025-06-12 | 7,837 | $53.99 | $423.1K | 556,487 | SEC↗ |
| Cheng Andrew | President and CEO | S Sale | 2025-06-10 | 2025-06-12 | 14,842 | $53.76 | $797.9K | 579,482 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | M Exercise deriv | 2025-06-06 | 2025-06-09 | 24,611 | — | $0 | 32,433 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | M Exercise deriv | 2025-06-06 | 2025-06-09 | 389 | — | $0 | 0 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | M Exercise | 2025-06-06 | 2025-06-09 | 24,611 | $21.09 | $519.0K | 194,332 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | M Exercise | 2025-06-06 | 2025-06-09 | 389 | $21.10 | $8.2K | 194,721 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | S Sale | 2025-06-06 | 2025-06-09 | 25,000 | $55.04 | $1.38M | 169,721 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | M Exercise deriv | 2025-06-05 | 2025-06-09 | 12,500 | — | $0 | 389 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | S Sale | 2025-06-05 | 2025-06-09 | 9,350 | $53.37 | $499.0K | 172,871 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | S Sale | 2025-06-05 | 2025-06-09 | 3,150 | $53.84 | $169.6K | 169,721 | SEC↗ |
| Rolph Timothy | Chief Scientific Officer | M Exercise | 2025-06-05 | 2025-06-09 | 12,500 | $21.10 | $263.8K | 182,221 | SEC↗ |
| Judy Chou | Director | A Award | 2025-06-03 | 2025-06-05 | 9,398 | — | $0 | 9,398 | SEC↗ |
| Graham G. Walmsley | Director | A Award | 2025-06-03 | 2025-06-05 | 9,398 | — | $0 | 11,566 | SEC↗ |
| Heyman Tomas J. | Director | A Award | 2025-06-03 | 2025-06-05 | 9,398 | — | $0 | 9,398 | SEC↗ |
| Xu Yuan | Director | A Award | 2025-06-03 | 2025-06-05 | 9,398 | — | $0 | 9,398 | SEC↗ |
| Iwicki Mark T | Director | A Award | 2025-06-03 | 2025-06-05 | 9,398 | — | $0 | 9,398 | SEC↗ |
| Harrison Seth Loring | Director | A Award | 2025-06-03 | 2025-06-05 | 9,398 | — | $0 | 145,699 | SEC↗ |
| Henderson Jane | Director | A Award | 2025-06-03 | 2025-06-05 | 9,398 | — | $0 | 9,398 | SEC↗ |
| Lamy Patrick | Senior VP, Commercial Strate | M Exercise deriv | 2025-06-02 | 2025-06-04 | 4,000 | — | $0 | 66,182 | SEC↗ |
| Lamy Patrick | Senior VP, Commercial Strate | S Sale | 2025-06-02 | 2025-06-04 | 600 | $49.40 | $29.6K | 36,892 | SEC↗ |
| Lamy Patrick | Senior VP, Commercial Strate | S Sale | 2025-06-02 | 2025-06-04 | 3,300 | $50.46 | $166.5K | 33,592 | SEC↗ |
| Lamy Patrick | Senior VP, Commercial Strate | S Sale | 2025-06-02 | 2025-06-04 | 100 | $51.04 | $5.1K | 33,492 | SEC↗ |
| Lamy Patrick | Senior VP, Commercial Strate | M Exercise | 2025-06-02 | 2025-06-04 | 4,000 | $19.87 | $79.5K | 37,492 | SEC↗ |
| Lamy Patrick | Senior VP, Commercial Strate | M Exercise deriv | 2025-05-22 | 2025-05-23 | 4,000 | — | $0 | 84,904 | SEC↗ |
| Lamy Patrick | Senior VP, Commercial Strate | S Sale | 2025-05-22 | 2025-05-23 | 4,000 | $50.00 | $200.0K | 33,492 | SEC↗ |
| Lamy Patrick | Senior VP, Commercial Strate | M Exercise | 2025-05-22 | 2025-05-23 | 4,000 | $44.37 | $177.5K | 37,492 | SEC↗ |
| Yale Catriona | Chief Development Officer | M Exercise deriv | 2025-05-15 | 2025-05-19 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Yale Catriona | Chief Development Officer | S Sale | 2025-05-15 | 2025-05-19 | 4,384 | $39.91 | $175.0K | 95,034 | SEC↗ |
| Yale Catriona | Chief Development Officer | S Sale | 2025-05-15 | 2025-05-19 | 2,779 | $39.46 | $109.7K | 99,418 | SEC↗ |
| Yale Catriona | Chief Development Officer | S Sale | 2025-05-15 | 2025-05-19 | 2,837 | $38.20 | $108.4K | 102,197 | SEC↗ |
| Yale Catriona | Chief Development Officer | M Exercise | 2025-05-15 | 2025-05-19 | 10,000 | $21.10 | $211.0K | 105,034 | SEC↗ |
| Cheng Andrew | President and CEO | S Sale | 2025-05-12 | 2025-05-13 | 22,800 | $41.63 | $949.2K | 594,324 | SEC↗ |
| Cheng Andrew | President and CEO | S Sale | 2025-05-12 | 2025-05-13 | 7,200 | $41.00 | $295.2K | 617,124 | SEC↗ |
| Lamy Patrick | Senior VP, Commercial Strate | M Exercise deriv | 2025-05-07 | 2025-05-09 | 8,000 | — | $0 | 70,182 | SEC↗ |
| Lamy Patrick | Senior VP, Commercial Strate | S Sale | 2025-05-07 | 2025-05-09 | 4,701 | $42.31 | $198.9K | 36,791 | SEC↗ |
| Lamy Patrick | Senior VP, Commercial Strate | M Exercise | 2025-05-07 | 2025-05-09 | 8,000 | $19.87 | $159.0K | 41,492 | SEC↗ |
| Lamy Patrick | Senior VP, Commercial Strate | S Sale | 2025-05-07 | 2025-05-09 | 3,299 | $42.76 | $141.1K | 33,492 | SEC↗ |